S100A12 and inflammatory bowel disease: However, regarding the crucial differences in PTX3 and S100A12 serum profiles in patients with Crohn’s disease and ulcerative colitis, together with its varied synthesis and release during the diseases, our study indicate that these biomarkers might be useful in the differential diagnosis of IBD.